A topic in the Open Knowledge Graph — a free, open map of 15,290 topics and the order to learn them in.
Blood glucose is tightly regulated at 70-100 mg/dL (3.9-5.6 mM) through coordinated hormonal action on liver, adipose tissue, and muscle. In the fed state (high blood glucose), insulin secretion from pancreatic beta cells promotes glucose uptake (GLUT4 translocation in muscle and fat via signaling cascade), glycogen synthesis, and fatty acid synthesis, shifting metabolism toward anabolic pathways. In the fasted state (low blood glucose), glucagon and epinephrine promote hepatic glycogenolysis and gluconeogenesis, stimulate lipolysis in adipose tissue, and suppress glucose utilization in non-essential tissues to maintain blood glucose. A glucose counter-regulatory system involving glucagon, epinephrine, cortisol, and growth hormone prevents severe hypoglycemia even during prolonged fasting.
Measure blood glucose and hormone levels (insulin, glucagon, epinephrine) during fasting and in response to meal consumption. Perform intravenous glucose tolerance tests and hyperinsulinemic-euglycemic clamps to assess insulin sensitivity and glucose counter-regulation.
Glucagon does not cause hyperglycemia independently; it restores normoglycemia during fasting. In diabetes, hyperglycemia results from inadequate insulin action, not from excess glucagon.
From your study of carbohydrate homeostasis and fed/fasted state metabolism, you understand the individual biochemical pathways — glycolysis, glycogen synthesis, gluconeogenesis, lipolysis — and how they are activated or suppressed. Glucose homeostasis is the integrated system that coordinates all of these pathways in real time to keep blood glucose within a remarkably narrow range of 70–100 mg/dL, whether you have just eaten a large meal or have been fasting for 24 hours. The key insight is that this is not a single pathway but a hormonal control system operating across multiple organs simultaneously.
The fed state begins when you eat and blood glucose rises. Pancreatic beta cells detect the increase and secrete insulin, which acts as an anabolic master switch. In skeletal muscle and adipose tissue, insulin triggers the translocation of GLUT4 transporters to the cell surface, dramatically increasing glucose uptake. In the liver, insulin activates glycogen synthase (storing glucose as glycogen) and stimulates lipogenesis (converting excess glucose into fatty acids for long-term storage). At the same time, insulin suppresses gluconeogenesis and glycogenolysis — there is no need to produce glucose when it is flooding in from the gut. The net effect is to rapidly clear glucose from the blood and channel it into storage, bringing blood glucose back toward the baseline within a few hours of a meal.
As hours pass without food, the system reverses. Falling blood glucose causes beta cells to reduce insulin secretion while pancreatic alpha cells increase glucagon release. Glucagon acts primarily on the liver, activating glycogenolysis (breaking down glycogen to release glucose) and gluconeogenesis (synthesizing new glucose from lactate, amino acids, and glycerol). Simultaneously, falling insulin removes the brake on lipolysis in adipose tissue, releasing free fatty acids that muscle and other tissues can oxidize for energy — sparing glucose for the brain, which depends on it almost exclusively. If fasting continues beyond 12–24 hours and glycogen stores are depleted, gluconeogenesis becomes the dominant source of blood glucose, and ketone body production rises to provide an alternative fuel for the brain.
The body maintains multiple layers of defense against hypoglycemia (dangerously low blood glucose), because the brain cannot tolerate glucose deprivation for more than a few minutes. If glucagon alone is insufficient, epinephrine is released from the adrenal medulla, powerfully stimulating glycogenolysis and lipolysis while suppressing insulin secretion. With prolonged stress or fasting, cortisol and growth hormone join the counter-regulatory response, promoting gluconeogenesis and insulin resistance in peripheral tissues to reserve glucose for the brain. This layered defense system — glucagon first, then epinephrine, then cortisol and growth hormone — explains why healthy individuals virtually never experience severe hypoglycemia even during extended fasts, and why the loss of these counter-regulatory mechanisms in diabetes makes hypoglycemia from insulin therapy so dangerous.